They can suppress the expression of proinflammatory cytokines such as interferon-γ, tumor necrosis factor-α, and various chemokines in different cell types (54), potentially mitigating the chronic low-grade inflammation commonly observed in individuals with T2DM and CVD. The gene discussed is TNF; the disease is type 2 diabetes mellitus.